Pharmaceutical & Product Liability
Cossich, Sumich, Parsiola & Taylor are currently reviewing claims of patients who took Belviq, also known as lorcaserin, who are subsequently diagnosed with cancer. Belviq was marketed and sold in the United States as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with a body mass index greater than or equal to 30 kg/m2 or adult patients with a BMI greater than or equal to 27 kg/m2 and at least one weight-related comorbid condition. Despite preliminary indications that Belviq was a carcinogen, it was marketed in the United States from 2013 to 2020.
In 2020, the FDA required the manufacturer to issue a recall of Belviq following a multi-year study that found Belviq users had an elevated risk of cancer. The FDA stated that “the risks of lorcaserin outweigh its benefits” and Belviq is no longer prescribed in the United States. According to the study, 7.2% of people taking Belviq developed cancer. Belviq is known to cause three types of cancer; pancreatic, colorectal and lung. The difference in the incidence of cancer increases with longer duration on lorcaserin. Subsequent to studies confirming higher incidences of cancer for patients taking Belviq, the drug was removed from the market.
Who is Eligible for a Belviq Lawsuit?
If you took Belviq (lorcaserin) are over the age of 18 and were subsequently diagnosed with cancer you may be eligible to pursue a claim against the manufacturers of the drug. If a loved one took Belviq and was subsequently diagnosed with cancer, you may call on their behalf.
What is the time limit for pursuing a Belviq claim?
The time limit for pursuing a Belviq claim may depend on a variety of factors including the dates you took Belviq, the date you or a loved one was diagnosed with cancer, and the state of your residence. A consultation with an attorney is necessary to better determine whether you are eligible to pursue a claim.
How much does a consultation cost?
There is no charge for a consultation, and we can evaluate your potential claim free of charge.